http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022257253-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6a6f422b091ba12ea61d4adbf1b0e8e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2021-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce1fc5438a4758a14373d2af28859fde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45eb9c9f227e36d668b138360303631b
publicationDate 2022-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022257253-A1
titleOfInvention Use of ginsenoside rg2 in preparation of drug for treating myelosuppression and drug containing ginsenoside rg2
abstract The use of ginsenoside Rg2 in the preparation of a drug for treating myelosuppression and a drug containing ginsenoside Rg2. When chemotherapy causes myelosuppression, the use of ginsenoside Rg2 can promote the recovery of the ingredients of bone marrow cells, increase the number of bone marrow nucleated cells, remarkably increase the number of granulocyte-monocyte colony forming units and pre-B colony forming units in bone marrow, and promote the proliferation of granulocyte-monocyte and pre-B hematopoietic progenitor cells, which indicates that the ginsenoside Rg2 has the effect of promoting medullary hematopoiesis.
priorityDate 2021-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID320930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21599924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394204
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6331297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551219

Total number of triples: 30.